Feasibility of Cognitively-Based Compassion Training (CBCT) for breast cancer survivors

a randomized, wait list controlled pilot study

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Purpose: This study assessed the feasibility of a meditation-based program called Cognitively-Based Compassion Training (CBCT) with breast cancer survivors. Enrollment and participant satisfaction with a novel intervention, adherence to program requirements, and differences between the intervention group and wait list controls on self-report measures were also assessed. Additionally, cortisol, a stress-related endocrine biomarker, was assessed. Methods: Participants (n = 33) were randomly assigned to CBCT or the wait list. CBCT provided eight weekly, 2-h classes and a “booster” CBCT session 4 weeks later. CBCT participants were expected to attend classes and meditate between classes at least three times per week. Pre-/post-intervention and follow-up questionnaires measured symptom change (depression, intrusive thoughts, perceived stress, fear of cancer recurrence, fatigue/vitality, loneliness, and quality of life). Saliva samples were collected at the same periods to assess the slope of diurnal cortisol activity. Results: Enrollment, class attendance, home practice time, and patient satisfaction exceeded expectations. Compared to controls, post-intervention, the CBCT group showed suggestions of significant improvements in depression, avoidance of intrusive thoughts, functional impairment associated with fear of recurrence, mindfulness, and vitality/fatigue. At follow-up, less perceived stress and higher mindfulness were also significant in the CBCT group. No significant changes were observed on any other measure including diurnal cortisol activity. Conclusions: Within the limits of a pilot feasibility study, results suggest that CBCT is a feasible and highly satisfactory intervention potentially beneficial for the psychological well-being of breast cancer survivors. However, more comprehensive trials are needed to provide systematic evidence. Relevance: CBCT may be very beneficial for improving depression and enhancing well-being during breast cancer survivorship.

Original languageEnglish (US)
Pages (from-to)3599-3608
Number of pages10
JournalSupportive Care in Cancer
Volume23
Issue number12
DOIs
StatePublished - Aug 16 2015

Fingerprint

Survivors
Breast Neoplasms
Mindfulness
Hydrocortisone
Feasibility Studies
Depression
Fear
Fatigue
Meditation
Recurrence
Loneliness
Patient Satisfaction
Saliva
Self Report
Survival Rate
Biomarkers
Quality of Life
Psychology
Neoplasms

Keywords

  • Breast cancer
  • Compassion
  • Depression
  • Fear of cancer recurrence
  • Meditation
  • Stress
  • Survivorship

ASJC Scopus subject areas

  • Oncology

Cite this

@article{5cedfebc56ac4a6097bef299cd1fd1d9,
title = "Feasibility of Cognitively-Based Compassion Training (CBCT) for breast cancer survivors: a randomized, wait list controlled pilot study",
abstract = "Purpose: This study assessed the feasibility of a meditation-based program called Cognitively-Based Compassion Training (CBCT) with breast cancer survivors. Enrollment and participant satisfaction with a novel intervention, adherence to program requirements, and differences between the intervention group and wait list controls on self-report measures were also assessed. Additionally, cortisol, a stress-related endocrine biomarker, was assessed. Methods: Participants (n = 33) were randomly assigned to CBCT or the wait list. CBCT provided eight weekly, 2-h classes and a “booster” CBCT session 4 weeks later. CBCT participants were expected to attend classes and meditate between classes at least three times per week. Pre-/post-intervention and follow-up questionnaires measured symptom change (depression, intrusive thoughts, perceived stress, fear of cancer recurrence, fatigue/vitality, loneliness, and quality of life). Saliva samples were collected at the same periods to assess the slope of diurnal cortisol activity. Results: Enrollment, class attendance, home practice time, and patient satisfaction exceeded expectations. Compared to controls, post-intervention, the CBCT group showed suggestions of significant improvements in depression, avoidance of intrusive thoughts, functional impairment associated with fear of recurrence, mindfulness, and vitality/fatigue. At follow-up, less perceived stress and higher mindfulness were also significant in the CBCT group. No significant changes were observed on any other measure including diurnal cortisol activity. Conclusions: Within the limits of a pilot feasibility study, results suggest that CBCT is a feasible and highly satisfactory intervention potentially beneficial for the psychological well-being of breast cancer survivors. However, more comprehensive trials are needed to provide systematic evidence. Relevance: CBCT may be very beneficial for improving depression and enhancing well-being during breast cancer survivorship.",
keywords = "Breast cancer, Compassion, Depression, Fear of cancer recurrence, Meditation, Stress, Survivorship",
author = "Dodds, {Sally E} and Pace, {Thaddeus Wesley Warren} and Bell, {Melanie L} and Mallorie Fiero and Negi, {Lobsang Tenzin} and Raison, {Charles L} and Weihs, {Karen L}",
year = "2015",
month = "8",
day = "16",
doi = "10.1007/s00520-015-2888-1",
language = "English (US)",
volume = "23",
pages = "3599--3608",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Feasibility of Cognitively-Based Compassion Training (CBCT) for breast cancer survivors

T2 - a randomized, wait list controlled pilot study

AU - Dodds, Sally E

AU - Pace, Thaddeus Wesley Warren

AU - Bell, Melanie L

AU - Fiero, Mallorie

AU - Negi, Lobsang Tenzin

AU - Raison, Charles L

AU - Weihs, Karen L

PY - 2015/8/16

Y1 - 2015/8/16

N2 - Purpose: This study assessed the feasibility of a meditation-based program called Cognitively-Based Compassion Training (CBCT) with breast cancer survivors. Enrollment and participant satisfaction with a novel intervention, adherence to program requirements, and differences between the intervention group and wait list controls on self-report measures were also assessed. Additionally, cortisol, a stress-related endocrine biomarker, was assessed. Methods: Participants (n = 33) were randomly assigned to CBCT or the wait list. CBCT provided eight weekly, 2-h classes and a “booster” CBCT session 4 weeks later. CBCT participants were expected to attend classes and meditate between classes at least three times per week. Pre-/post-intervention and follow-up questionnaires measured symptom change (depression, intrusive thoughts, perceived stress, fear of cancer recurrence, fatigue/vitality, loneliness, and quality of life). Saliva samples were collected at the same periods to assess the slope of diurnal cortisol activity. Results: Enrollment, class attendance, home practice time, and patient satisfaction exceeded expectations. Compared to controls, post-intervention, the CBCT group showed suggestions of significant improvements in depression, avoidance of intrusive thoughts, functional impairment associated with fear of recurrence, mindfulness, and vitality/fatigue. At follow-up, less perceived stress and higher mindfulness were also significant in the CBCT group. No significant changes were observed on any other measure including diurnal cortisol activity. Conclusions: Within the limits of a pilot feasibility study, results suggest that CBCT is a feasible and highly satisfactory intervention potentially beneficial for the psychological well-being of breast cancer survivors. However, more comprehensive trials are needed to provide systematic evidence. Relevance: CBCT may be very beneficial for improving depression and enhancing well-being during breast cancer survivorship.

AB - Purpose: This study assessed the feasibility of a meditation-based program called Cognitively-Based Compassion Training (CBCT) with breast cancer survivors. Enrollment and participant satisfaction with a novel intervention, adherence to program requirements, and differences between the intervention group and wait list controls on self-report measures were also assessed. Additionally, cortisol, a stress-related endocrine biomarker, was assessed. Methods: Participants (n = 33) were randomly assigned to CBCT or the wait list. CBCT provided eight weekly, 2-h classes and a “booster” CBCT session 4 weeks later. CBCT participants were expected to attend classes and meditate between classes at least three times per week. Pre-/post-intervention and follow-up questionnaires measured symptom change (depression, intrusive thoughts, perceived stress, fear of cancer recurrence, fatigue/vitality, loneliness, and quality of life). Saliva samples were collected at the same periods to assess the slope of diurnal cortisol activity. Results: Enrollment, class attendance, home practice time, and patient satisfaction exceeded expectations. Compared to controls, post-intervention, the CBCT group showed suggestions of significant improvements in depression, avoidance of intrusive thoughts, functional impairment associated with fear of recurrence, mindfulness, and vitality/fatigue. At follow-up, less perceived stress and higher mindfulness were also significant in the CBCT group. No significant changes were observed on any other measure including diurnal cortisol activity. Conclusions: Within the limits of a pilot feasibility study, results suggest that CBCT is a feasible and highly satisfactory intervention potentially beneficial for the psychological well-being of breast cancer survivors. However, more comprehensive trials are needed to provide systematic evidence. Relevance: CBCT may be very beneficial for improving depression and enhancing well-being during breast cancer survivorship.

KW - Breast cancer

KW - Compassion

KW - Depression

KW - Fear of cancer recurrence

KW - Meditation

KW - Stress

KW - Survivorship

UR - http://www.scopus.com/inward/record.url?scp=84945465675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945465675&partnerID=8YFLogxK

U2 - 10.1007/s00520-015-2888-1

DO - 10.1007/s00520-015-2888-1

M3 - Article

VL - 23

SP - 3599

EP - 3608

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 12

ER -